10:44 AM
Aug 16, 2017
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Brain cancer

Cell culture studies suggest activating IRF3 or inhibiting its negative regulator CSNK2 could help treat glioblastoma multiforme (GBM). In mouse brain slices co-cultured with a patient-derived GBM cell line, vector-mediated constitutively active IRF3 in the GBM cells decreased the...

Read the full 193 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >